Trials / Recruiting
RecruitingNCT02724670
Study of MR-based IGRT for Prostate Cancer
Single-arm Phase II Study of MR(Magnetic Resonance Imaging)-Based Image-guided Radiotherapy for Prostate Cancer
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 78 (estimated)
- Sponsor
- University Hospital Tuebingen · Academic / Other
- Sex
- Male
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
MR (Magnetic Resonance Imaging) - based IGRT (image-guided radiotherapy) for patients with prostate carcinoma.
Detailed description
Single arm, phase II study, MR (Magnetic Resonance Imaging) - based IGRT (Image-guided radiotherapy) of prostate cancer. Primary endpoint: Grade 2+ GI (gastrointestinal) and genitourinary (GU) toxicity after 2 years.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | IGRT | MR-based IGRT |
Timeline
- Start date
- 2016-03-01
- Primary completion
- 2020-06-01
- Completion
- 2028-09-01
- First posted
- 2016-03-31
- Last updated
- 2019-09-25
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT02724670. Inclusion in this directory is not an endorsement.